Publications by authors named "Adele Noe"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

19,178

Total Likes

348

Extended Reach

139,470

Social Features

26
N
NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study.
Domingo Pascual-Figal, Rolf Wachter, Michele Senni, Weibin Bao, Adele Noè, Heike Schwende, Dmytro Butylin, Margaret F Prescott,

October 2020

Videos about Article: user user user 1

4 22 2

View All Article and Social Media Activity
I
Influence of diabetes on sacubitril/valsartan titration and clinical outcomes in patients hospitalized for heart failure.
Klaus K Witte, Rolf Wachter, Michele Senni, Jan Belohlavek, Ewa Straburzynska-Migaj

ESC Heart Fail· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initiation of sacubitril/valsartan shortly after hospitalisation for acutely decompensated heart failure in patients with newly diagnosed (de novo) heart failure: a subgroup analysis of the TRANSITION study.
Michele Senni, Rolf Wachter, Klaus K Witte, Ewa Straburzynska-Migaj, Jan Belohlavek, Adele Noe

Eur J Heart Fail· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study.
Rolf Wachter, Michele Senni, Jan Belohlavek, Ewa Straburzynska-Migaj, Klaus K Witte

Eur J Heart Fail· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of TRANSITION: a randomized trial of pre-discharge vs. post-discharge initiation of sacubitril/valsartan.
Domingo Pascual-Figal, Rolf Wachter, Michele Senni, Jan Belohlavek, Adele Noè

ESC Heart Fail· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Pradigastat, a Diacylglycerol Acyltransferase 1 Inhibitor, on the QTcF Interval in Humans.
Charles D Meyers, Adele Noe, Atish Salunke, Aishwarya Movva, Kenneth Kulmatycki

Clin Pharmacol Drug Dev· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The DGAT1 inhibitor pradigastat does not induce photosensitivity in healthy human subjects: a randomized controlled trial using three defined sunlight exposure conditions.
Daniel Bauer, Rachel L Soon, Kenneth Kulmatycki, Yuming Chen, Adele Noe

Photochem Photobiol Sci· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry.
Gerasimos Filippatos, Sadiya Sana Khan, Andrew P Ambrosy, John G F Cleland, Sean P Collins, Adele Noe

Eur J Heart Fail· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and pharmacodynamic characteristics of single-dose Canakinumab in patients with type 2 diabetes mellitus.
Adele Noe, Campbell Howard, Tom Thuren, Ann Taylor, Andrej Skerjanec

Clin Ther· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies.
Campbell Howard, Adele Noe, Andrej Skerjanec, Björn Holzhauer, Margaret Wernsing

Cardiovasc Diabetol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi).
Jessie Gu, Adele Noe, Priya Chandra, Suliman Al-Fayoumi, Monica Ligueros-Saylan

J Clin Pharmacol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiation of innovator versus generic cyclosporine via a drug interaction on sirolimus.
John M Kovarik, Adele Noe, Yibin Wang, Irene Mueller, Gilberto DeNucci

Eur J Clin Pharmacol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical development of an everolimus pediatric formulation: relative bioavailability, food effect, and steady-state pharmacokinetics.
John M Kovarik, Adele Noe, Stephane Berthier, Louis McMahon, Wayne K Langholff

J Clin Pharmacol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stromelysin-1 activation correlates with invasiveness in squamous cell carcinoma.
Tiziana De Angelis, Adele Noè, Mitali Chatterjee, Joy Mulholland

J Invest Dermatol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis